Form 4: Dexcom Executive Sells Shares to Cover Tax Obligations After Performance Stock Units Vest

Dexcom's EVP, Chief Operating Officer, Jacob Steven Leach, sold 2,634 shares to cover tax obligations after performance stock units vested.

Summary

• Jacob Steven Leach, EVP and Chief Operating Officer of Dexcom Inc., had 7,107 performance stock units vest on January 28, 2025.
• Following the vesting, Mr. Leach sold 2,634 shares on January 29, 2025, at a price of $86.9142 per share to cover tax withholding obligations.
• After these transactions, Mr. Leach directly owns 268,644 shares of Dexcom stock.
• Mr. Leach also has indirect ownership of 47,296 shares held by the Gregg Family Grandchildren's Trust, where his spouse is a trustee.
• The reported direct holdings include 51,972 unvested restricted stock units that will vest through March 8, 2027.

Sentiment

Score: 5

Explanation: This is a routine transaction related to executive compensation and does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a standard practice across publicly listed companies.
• Many companies, such as Medtronic and Abbott, use similar equity compensation plans that result in similar transactions.
• The vesting schedules and 'sell to cover' mechanisms are common features in executive compensation packages.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Dexcom, executive, stock, performance stock units, vesting, tax obligations, share sale, restricted stock units, insider trading